[go: up one dir, main page]

EP1575359A4 - Reduction of reactive oxygen species in chronic wound management - Google Patents

Reduction of reactive oxygen species in chronic wound management

Info

Publication number
EP1575359A4
EP1575359A4 EP03808544A EP03808544A EP1575359A4 EP 1575359 A4 EP1575359 A4 EP 1575359A4 EP 03808544 A EP03808544 A EP 03808544A EP 03808544 A EP03808544 A EP 03808544A EP 1575359 A4 EP1575359 A4 EP 1575359A4
Authority
EP
European Patent Office
Prior art keywords
reduction
oxygen species
reactive oxygen
chronic wound
wound management
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03808544A
Other languages
German (de)
French (fr)
Other versions
EP1575359A1 (en
Inventor
Stephen H Monroe
Hans Hoekstra
Den Berg A J J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greystone Medical Group Inc
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Publication of EP1575359A1 publication Critical patent/EP1575359A1/en
Publication of EP1575359A4 publication Critical patent/EP1575359A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
EP03808544A 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management Withdrawn EP1575359A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43619702P 2002-12-23 2002-12-23
US436197P 2002-12-23
PCT/US2003/041038 WO2004057965A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Publications (2)

Publication Number Publication Date
EP1575359A1 EP1575359A1 (en) 2005-09-21
EP1575359A4 true EP1575359A4 (en) 2009-08-05

Family

ID=32682357

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03808544A Withdrawn EP1575359A4 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Country Status (6)

Country Link
EP (1) EP1575359A4 (en)
JP (1) JP2006511585A (en)
CN (1) CN1744819A (en)
AU (1) AU2003303335A1 (en)
CA (1) CA2511440A1 (en)
WO (1) WO2004057965A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6227856B2 (en) * 2008-04-01 2017-11-08 アントイポデアン ファーマシューティカルズ, インコーポレイテッド Composition and method for skin care
WO2011022757A1 (en) * 2009-08-24 2011-03-03 Queensland University Of Technology Purine-targeted diagnosis and therapy of wounds
WO2013016255A1 (en) * 2011-07-28 2013-01-31 3M Innovative Properties Company Wound-healing compositions and method of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777A1 (en) * 1984-05-07 1985-11-07 Gödecke AG, 1000 Berlin Topical pharmaceutical formulations, process for the preparation thereof and the use thereof for promoting wound granulation and epithelisation
WO2003045366A1 (en) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Treatment of wounds and compositions employed

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011010A2 (en) * 1992-11-06 1994-05-26 H.E. Stanley Pharmaceuticals, Inc. Compositions of oak bark extract, related synthetic compositions, and method of using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777A1 (en) * 1984-05-07 1985-11-07 Gödecke AG, 1000 Berlin Topical pharmaceutical formulations, process for the preparation thereof and the use thereof for promoting wound granulation and epithelisation
WO2003045366A1 (en) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Treatment of wounds and compositions employed

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDREWS M ET AL: "The role of zinc in wound healing", ADVANCES IN WOUND CARE : THE JOURNAL FOR PREVENTION AND HEALING,, vol. 12, no. 3, 1 April 1999 (1999-04-01), pages 137 - 138, XP009112199, ISSN: 1076-2191 *
See also references of WO2004057965A1 *

Also Published As

Publication number Publication date
CA2511440A1 (en) 2004-07-15
WO2004057965A1 (en) 2004-07-15
CN1744819A (en) 2006-03-08
EP1575359A1 (en) 2005-09-21
JP2006511585A (en) 2006-04-06
AU2003303335A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
GB2406523B (en) Improvements in and relating to the formation of knots
AU2003294366A8 (en) Wound dressing
AU151743S (en) Wound dressing
EP1802214B8 (en) Compact having slidable in and out structure of content case
AU2003209594A1 (en) Quinazoline compounds useful in therapy
GB0324429D0 (en) Improvements in and relating to gaming systems
EP1481703A4 (en) Oxygen enricher
GB0215023D0 (en) Wound dressing
EP1813388A4 (en) Polishing tape and polishing method
IL169323A0 (en) Pyrazole-derivatives as factor xa inhibitors
GB0307140D0 (en) Gaming apparatus with power saving feature
EP1472079A4 (en) Radiation-cured correction tape
EP1575359A4 (en) Reduction of reactive oxygen species in chronic wound management
AU2003207503A8 (en) Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
SG110107A1 (en) Compound and use in treatment
HK1081074A (en) Reduction of reactive oxygen species in chronic wound management
AU2003295178A8 (en) Sinusoid selection in audio encoding
GB2394428B (en) Improvements in and relating to filters
GB0213596D0 (en) Improvements in and relating to catheter control
GB0217220D0 (en) Improvements in and relating to tape measures
AU2003203237A1 (en) Structure of skylight in greenhouse
GB0224180D0 (en) Improved oxygen storage component
GB0404222D0 (en) Unitary construction block for use in building industry and building structure made therefrom
TW570365U (en) Dust-proof and humidity-proof cover structure of audio I/O port
GB2388994B (en) Improvements in and relating to sound emitting devices

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050630

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1081074

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20090706

17Q First examination report despatched

Effective date: 20110218

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110629

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1081074

Country of ref document: HK